Revvity (RVTY) Change in Accured Expenses (2009 - 2026)
Revvity's (RVTY) quarterly Change in Accured Expenses came in at -$4.2 million in Q3 2026, up 70.84% on a YoY basis from -$2.5 million in Q3 2025, and up 94.39% quarter-over-quarter from -$74.7 million in Q2 2026.
Analysis
Revvity (RVTY) Change in Accured Expenses (2009 - 2026) Analysis & Trends
Revvity (RVTY) has reported Change in Accured Expenses for 18 consecutive years, with -$4.2 million the latest figure, recorded in Q3 2026.
- For the quarter ending Q3 2026, Change in Accured Expenses rose 70.84% year-over-year to -$4.2 million; the trailing twelve-month figure through Jul 2026 stood at -$47.6 million (down 169.14% YoY), and the FY2025 full-year result was -$17.9 million, up 16.41% from the prior year.
- Change in Accured Expenses improved to -$4.2 million in Q3 2026 per RVTY's latest filing, from -$74.7 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $92.8 million in Q4 2024 and bottomed at -$133.7 million in Q3 2023.
- Historically, Change in Accured Expenses has averaged -$37.0 million across 5 years, with a median of -$39.9 million in 2024.
- The sharpest annual moves came in 2024 and 2026: Change in Accured Expenses surged 197.74% in 2024, then slumped 114.56% in 2026.
- Over 5 years, Change in Accured Expenses stood at -$105.5 million in 2022, then soared by 129.56% to $31.2 million in 2023, then soared by 197.74% to $92.8 million in 2024, then sank by 44.95% to $51.1 million in 2025, then sank by 108.2% to -$4.2 million in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered -$4.2 million, -$74.7 million, and $51.1 million for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | - |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | -249.00 Mn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 34.00 Mn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 23.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | -4.19 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 3.53 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | - |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 12.13 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 3.12 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | -91.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 5, 2026 | -4.19 Mn |
| Apr 5, 2026 | -74.69 Mn |
| Dec 28, 2025 | 51.11 Mn |
| Sep 28, 2025 | -19.81 Mn |
| Jun 29, 2025 | -14.37 Mn |
| Mar 30, 2025 | -34.81 Mn |
| Dec 29, 2024 | 92.84 Mn |
| Sep 29, 2024 | -61.34 Mn |
| Jun 30, 2024 | -7.99 Mn |
| Mar 31, 2024 | -44.91 Mn |
| Dec 31, 2023 | 31.18 Mn |
| Oct 1, 2023 | -82.71 Mn |
| Jul 2, 2023 | -133.69 Mn |
| Apr 2, 2023 | -106.59 Mn |
| Jan 1, 2023 | -77.17 Mn |
| Apr 3, 2022 | -105.48 Mn |
| Oct 3, 2021 | -11.23 Mn |
| Jul 4, 2021 | -31.34 Mn |
| Apr 4, 2021 | -116.88 Mn |
| Jan 3, 2021 | 286.77 Mn |